<DOC>
	<DOCNO>NCT02094885</DOCNO>
	<brief_summary>To evaluate clinical utility Bioseal adjunct control bleed elective vascular surgery .</brief_summary>
	<brief_title>The Bioseal Vascular Study</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>1 . Subjects 18 75 year age ; 2 . Undergoing elective vascular surgical procedure presence appropriate Target Bleeding Site ( TBS ) require adjunct achieve hemostasis identify intraoperatively surgeon ; 3 . Able willing comply procedure require protocol ; 4 . Signed date write informed consent prior study related procedure . 1 . Subjects intraoperative finding may preclude conduct study procedure ; 2 . Intended use Fibrin Sealants ( include autologous Fibrin Sealants ) Bioseal TBS ; 3 . Subjects know intolerance blood product one component study product unwilling receive blood product ; 4 . Subjects know allergy previously use porcine derive product ; 5 . Female subject know breastfeed pregnant intend become pregnant clinical study period . 6 . The subject , opinion investigator , would suitable participation study . 7 . Subjects participate another trial within 30 day prior planned start treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>